Q32 Bio (QTTB) Operating Margin Growth (3y) (2021 - 2023)
Q32 Bio (QTTB) Operating Margin Growth (3y) (2021 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Q32 Bio |
177.18 Mn |
126.43 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
493,874.00 |
| Sep 30, 2023 |
456,695.00 |
| Jun 30, 2023 |
606,878.00 |
| Mar 31, 2023 |
595,594.00 |
| Dec 31, 2022 |
1.67 Mn |
| Sep 30, 2022 |
299,728.00 |
| Jun 30, 2022 |
360,642.00 |
| Mar 31, 2022 |
461,429.00 |
| Dec 31, 2021 |
695,009.00 |
| Sep 30, 2021 |
-85,236.00 |
| Jun 30, 2021 |
-43,483.00 |
| Mar 31, 2021 |
94,360.00 |
